Metoclopramide
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
Common Name | Metoclopramide(F05949) |
2D Structure | |
FRCD ID | F05949 |
CAS Number | 364-62-5 |
PubChem CID | 4168 |
Formula | C14H22ClN3O2 |
IUPAC Name | 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide |
InChI Key | TTWJBBZEZQICBI-UHFFFAOYSA-N |
InChI | InChI=1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19) |
Canonical SMILES | CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl |
Isomeric SMILES | CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl |
Synonyms | Metaclopromide metoclopramide 364-62-5 Metochlopramide Methochlopramide Metaclopramide Primperan Reliveran Reglan Metoclol |
Classifies | Predicted: Illegal Additives |
Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
Kingdom | Organic compounds |
Superclass | Benzenoids |
Class | Phenol ethers |
Subclass | Aminophenyl ethers |
Intermediate Tree Nodes | Not available |
Direct Parent | Aminophenyl ethers |
Alternative Parents | |
Molecular Framework | Aromatic homomonocyclic compounds |
Substituents | Aminophenyl ether - Methoxyaniline - Phenoxy compound - Anisole - Methoxybenzene - Aniline or substituted anilines - Alkyl aryl ether - Chlorobenzene - Halobenzene - Aryl chloride - Aryl halide - Monocyclic benzene moiety - Tertiary aliphatic amine - Tertiary amine - Organic 1,3-dipolar compound - Carboximidic acid - Carboximidic acid derivative - Propargyl-type 1,3-dipolar organic compound - Ether - Organopnictogen compound - Organic oxygen compound - Amine - Organic nitrogen compound - Hydrocarbon derivative - Primary amine - Organohalogen compound - Organochloride - Organonitrogen compound - Organooxygen compound - Aromatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as aminophenyl ethers. These are aromatic compounds that contain a phenol ether, which carries an amine group on the benzene ring. |
Properties
Property Name | Property Value |
---|---|
Molecular Weight | 299.799 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Complexity | 300 |
Monoisotopic Mass | 299.14 |
Exact Mass | 299.14 |
XLogP | 2.6 |
Formal Charge | 0 |
Heavy Atom Count | 20 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
ADMET
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9713 |
Human Intestinal Absorption | HIA+ | 0.9790 |
Caco-2 Permeability | Caco2+ | 0.8866 |
P-glycoprotein Substrate | Substrate | 0.7687 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8782 |
Non-inhibitor | 0.8783 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7276 |
Distribution | ||
Subcellular localization | Mitochondria | 0.8278 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8602 |
CYP450 2D6 Substrate | Substrate | 0.8918 |
CYP450 3A4 Substrate | Substrate | 0.6375 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9107 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
CYP450 2D6 Inhibitor | Inhibitor | 0.8931 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9099 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6223 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8367 |
Inhibitor | 0.8579 | |
AMES Toxicity | Non AMES toxic | 0.5378 |
Carcinogens | Non-carcinogens | 0.6142 |
Fish Toxicity | High FHMT | 0.8688 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9389 |
Honey Bee Toxicity | Low HBT | 0.8515 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.8050 |
Carcinogenicity (Three-class) | Non-required | 0.5827 |
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.1175 | LogS |
Caco-2 Permeability | 1.2230 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.6332 | LD50, mol/kg |
Fish Toxicity | 1.2793 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.4264 | pIGC50, ug/L |
MRLs
Food | Product Code | Country | MRLs | Application Date | Notes |
---|---|---|---|---|---|
Honey | Japan | 0.005ppm | |||
Other Aquatic Animal | Japan | 0.005ppm | |||
Crustaceans | Japan | 0.005ppm | |||
Shelled Molluscas | Japan | 0.005ppm | |||
Other Fish | Japan | 0.005ppm | |||
Perciformes | Japan | 0.005ppm | |||
Anguilliformes | Japan | 0.005ppm | |||
Salmoniformes | Japan | 0.005ppm | |||
Other Poultry,Eggs | Japan | 0.005ppm | |||
Chicken,Eggs | Japan | 0.005ppm | |||
Other Poultry Animals,Edible Offal | Japan | 0.005ppm | |||
Chicken,Edible Offal | Japan | 0.005ppm | |||
Other Poultry Animals,Kidney | Japan | 0.005ppm | |||
Chicken,Kidney | Japan | 0.005ppm | |||
Other Poultry Animals,Liver | Japan | 0.005ppm | |||
Chicken,Liver | Japan | 0.005ppm | |||
Other Poultry Animals,Fat | Japan | 0.005ppm | |||
Chicken,Fat | Japan | 0.005ppm | |||
Other Poultry Animals,Muscle | Japan | 0.005ppm | |||
Chicken,Muscle | Japan | 0.005ppm |
References
Title | Journal | Date | Pubmed ID |
---|---|---|---|
Reversible cholinesterase inhibitors as pretreatment for exposure toorganophosphates. A review. | J Appl Toxicol | 2018 Jul 19 | 30027640 |
Interaction Between 2 Nutraceutical Treatments and Host Immune Status in thePediatric Critical Illness Stress-Induced Immune Suppression ComparativeEffectiveness Trial. | JPEN J Parenter Enteral Nutr | 2017 Nov | 27660289 |
Using Chemoinformatics, Bioinformatics, and Bioassay to Predict and Explain theAntibacterial Activity of Nonantibiotic Food and Drug Administration Drugs. | Assay Drug Dev Technol | 2017 Apr | 28346800 |
Hepatopathy following consumption of a commercially available blue-green algae dietary supplement in a dog. | BMC Vet Res | 2015 Jun 19 | 26087767 |
Single-step multiresidue determination of ten multiclass veterinary drugs inpork, milk, and eggs using liquid chromatography with tandem mass spectrometry. | J Sep Sci | 2015 Aug | 26033853 |
Understanding variability in posaconazole exposure using an integrated populationpharmacokinetic analysis. | Antimicrob Agents Chemother | 2014 Nov | 25199779 |
Acetylcholinesterase inhibitors as pretreatment before acute exposure toorganophosphates: assessment using methyl-paraoxon. | CNS Neurol Disord Drug Targets | 2012 Dec | 23244429 |
Delayed gastric emptying: whom to test, how to test, and what to do. | Curr Treat Options Gastroenterol | 2006 Jul | 16836948 |
Influence of metoclopramide on gastroesophageal reflux in anesthetized dogs. | Am J Vet Res | 2006 Jan | 16426208 |
[Residue analysis of metoclopramide in bovine and swine tissues by HPLC andadministration experiment]. | Shokuhin Eiseigaku Zasshi | 2006 Dec | 17228790 |
Gastric electrical stimulation: an evidence-based analysis. | Ont Health Technol Assess Ser | 2006 | 23074486 |
Mechanisms by which food intake elevates circulating levels of hyaluronan inhumans. | J Intern Med | 2005 Nov | 16238682 |
Involvement of cholinergic neurons in the regulation of the ghrelin secretoryresponse to feeding in sheep. | Biochem Biophys Res Commun | 2003 May 2 | 12711315 |
Evidence that the anorexia induced by lipopolysaccharide is mediated by the 5-HT2C receptor. | Pharmacol Biochem Behav | 2003 Jan | 12479973 |
Metoclopramide and (or) cimetidine administration to sheep fed tall fescue. | Vet Hum Toxicol | 1996 Jun | 8727213 |
Lack of effect of NaCl and/or metoclopramide on exogenous (13C)-glucose oxidationduring exercise. | Int J Sports Med | 1996 Apr | 8739568 |
The effects of endophyte-infected tall fescue consumption and use of a dopamineantagonist on intake, digestibility, body temperature, and blood constituents in sheep. | J Anim Sci | 1993 Jan | 8454539 |
Potentiation by low doses of selected neuroleptics of food-induced conditionedplace preference in rats. | Psychopharmacology (Berl) | 1993 | 7870917 |
Pharmacokinetic interactions of cefprozil with food, propantheline,metoclopramide, and probenecid in healthy volunteers. | J Clin Pharmacol | 1992 Aug | 1487562 |
Physical properties of starch meals in vivo and in vitro and their influence ongastric emptying and oral glucose tolerance test. | Nutrition | 1991 Nov-Dec | 1802230 |